Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 22;55(9):836–846. doi: 10.1055/a-2038-0541

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

PMC Copyright notice

Fig. 3 — Graphs of surveillance outcomes, including advanced lesion development in the pouch body showing: a maximum adenoma count on record by 5, 10, 15, 20, 25, and 30 years; b contemporaneous adenoma count in the pouch body at the time an advanced lesion was diagnosed in the pouch body for the 39 patients with advanced lesions; c–e Kaplan–Meier curves for time to development of an advanced lesion in the pouch body: c for all patients; d (landmark at end of year 10 since surgery) stratified by presence or absence of an adenoma at the most recent surveillance prior to 10 years (of 104 patients still on study at year 10, 16 subsequently progressed to an advanced lesion; log-rank for differences in survival, P = 0.002); e (landmark at end of year 10 since surgery) stratified by largest adenoma size observed prior to 10 years (of 104 patients still on study at year 10, 16 subsequently progressed to an advanced lesion; log-rank for differences in survival, P < 0.001).